Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Naklo Nad Notecia

1 clinical trial in Naklo Nad Notecia, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Naklo Nad Notecia at a glance
1
clinical trial
  • Recruiting now0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 trial in Naklo Nad Notecia

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Darbepoetin Alfa
  • Sponsor:Genexine Inc.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Naklo Nad Notecia

What the registry says about research in the country

01 Nephrology Research

Innovative studies focusing on chronic kidney disease (CKD) and its complications, particularly examining treatment approaches for patients undergoing dialysis.

  • Anemia Management in CKD
  • Hemoglobin Level Control
  • Dialysis Patient Care

Current research compares different therapeutic agents for optimizing anemia treatment in dialysis patients.

02 Cardiovascular Studies

Research examining atherosclerotic cardiovascular disease in patients with end-stage kidney disease, with particular focus on inflammatory markers.

  • ESKD Complications
  • Cardiovascular Outcomes
  • Inflammatory Biomarkers

Trials evaluating novel therapeutic approaches for reducing cardiovascular risk in dialysis patients.

03 Therapeutic Interventions

Studies evaluating targeted treatments for complex medical conditions in patients receiving dialysis therapy.

  • Novel Drug Development
  • Treatment Efficacy
  • Patient Outcomes

Investigation of innovative therapeutic agents aimed at improving quality of life for dialysis patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.